Incannex Healthcare Limited Common Stock (IXHL) Stock Price

IXHLStock

$2.82−73.14%52W

Market Cap$35.38M

P/E—

PEG Ratio—

Div yield—

Beta1.84

IXHL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-30.24%

Price vs S&P 500 (4W)-17.87%

VGM Score26.42

Book Value / Share (Quarterly)$5.37

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-46.82%

Cash Flow / Share (Quarterly)$-1.03

Price vs S&P 500 (YTD)-85.67%

Gross Margin (TTM)116.40%

Net Profit Margin (TTM)-18137.76%

EPS (TTM)$-1.70

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-1.70

Revenue Growth (5Y)-31.02%

EPS (Annual)$-1.66

ROI (Annual)-350.18%

Gross Margin (Annual)48.22%

Net Profit Margin (5Y Avg)-42276.03%

Cash / Share (Quarterly)$5.40

ROA (Last FY)-229.30%

Revenue Growth TTM (YoY)-86.05%

EBITD / Share (TTM)$-1.96

ROE (5Y Avg)-184.95%

Operating Margin (TTM)-21430.61%

Cash Flow / Share (Annual)$-1.93

P/B Ratio0.53x

P/B Ratio (Quarterly)0.67x

Net Income / Employee (Annual)$-1,608,500

Net Interest Coverage (TTM)-664.59x

ROA (TTM)-25.15%

EPS Incl Extra (Annual)$-1.66

Current Ratio (Annual)2.86x

Quick Ratio (Quarterly)48.61x

3-Month Avg Trading Volume0.14M

52-Week Price Return-73.14%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)411.35x

Asset Turnover (Annual)0.00x

52-Week High$14.91

Operating Margin (5Y Avg)-56531.83%

EPS Excl Extra (Annual)$-1.66

CapEx CAGR (5Y)72.05%

26-Week Price Return-20.34%

Quick Ratio (Annual)2.82x

13-Week Price Return-11.04%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)48.81x

Enterprise Value$-32.34M

Revenue / Share Growth (5Y)25.35%

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)2.39x

Pretax Margin (Annual)-54517.44%

Cash / Share (Annual)$2.32

3-Month Return Std Dev48.63%

Net Income / Employee (TTM)$-1,608,500

ROE (Last FY)-350.18%

Net Interest Coverage (Annual)-688.36x

EPS Basic Excl Extra (Annual)$-1.66

Receivables Turnover (TTM)4.68x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.70

Receivables Turnover (Annual)7.14x

ROI (TTM)-26.35%

P/S Ratio (TTM)360.98x

Pretax Margin (5Y Avg)-42207.34%

Revenue / Share (Annual)$0.00

Forward P/E3.28x

Price vs S&P 500 (52W)-88.67%

Year-to-Date Return-73.74%

5-Day Price Return-2.76%

EPS Normalized (Annual)$-1.66

ROA (5Y Avg)-141.08%

Net Profit Margin (Annual)-54517.44%

Month-to-Date Return-12.96%

EBITD / Share (Annual)$-1.95

Operating Margin (Annual)-29373.26%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-184.95%

LT Debt / Equity (Quarterly)2.47x

EPS Basic Excl Extra (TTM)$-1.70

P/B Ratio (Annual)0.47x

Inventory Turnover (TTM)-0.41x

Pretax Margin (TTM)-18107.14%

Book Value / Share (Annual)$2.07

Price vs S&P 500 (13W)-13.73%

Beta1.84x

P/FCF (Annual)101.13x

Revenue / Share (TTM)$0.00

ROE (TTM)-26.35%

52-Week Low$2.49

gGradeF

mGradeC

vgmGradeD

IXHL Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Sep 25, 2026	-$0.57	-$0.17	+70.21%(+$0.40)
Q1 2026	May 15, 2026	-$0.84	-$0.49	+41.71%(+$0.35)
Q4 2025	Feb 13, 2026	-$0.93	-$0.85	+8.71%(+$0.08)
Q3 2025	Nov 14, 2025	-$18.09	-$0.92	+94.94%(+$17.17)
Q2 2025	Sep 29, 2025	-$13.47	-$23.26	-72.68%(-$9.79)

IXHL Analyst Recommendations

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
IXHLIncannex Healthcare Limited Common Stock	—	F	C	361.0x	-86.0%	116.4%	—	$2.82
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Incannex Healthcare Limited Common Stock

Incannex Healthcare is a clinical-stage pharmaceutical company developing cannabis-based therapeutics for Obstructive Sleep Apnea, Traumatic Brain Injury, Rheumatoid Arthritis, and various inflammatory conditions. The company holds an Australian license to import, export, and distribute medicinal cannabis and has commercialized a cannabinoid product line. Its research and development extends to both cannabis and psychedelic medicine applications.